Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1300 entries
Sorted by: Best Match Show Resources per page
Microbial monitoring and methods of sample collection: a GITMO survey (Gruppo Trapianto di Midollo Osseo).

Ecancermedicalscience

Gori E, Callea E, Alberani F, Orlando L.
PMID: 24834116
Ecancermedicalscience. 2014 Apr 10;8:421. doi: 10.3332/ecancer.2014.421. eCollection 2014.

UNLABELLED: The collection of microbiological samples represents an important aspect of care both for doctors as well as nurses. It is important to recognise and identify some key points, to avoid performing 'unnecessary' or 'incorrect' sampling, which may give...

Cite
Gori E, Callea E, Alberani F, et al. Microbial monitoring and methods of sample collection: a GITMO survey (Gruppo Trapianto di Midollo Osseo). Ecancermedicalscience. 2014;8:421doi: 10.3332/ecancer.2014.421.
Gori, E., Callea, E., Alberani, F., & Orlando, L. (2014). Microbial monitoring and methods of sample collection: a GITMO survey (Gruppo Trapianto di Midollo Osseo). Ecancermedicalscience, 8421. https://doi.org/10.3332/ecancer.2014.421
Gori, Erica, et al. "Microbial monitoring and methods of sample collection: a GITMO survey (Gruppo Trapianto di Midollo Osseo)." Ecancermedicalscience vol. 8 (2014): 421. doi: https://doi.org/10.3332/ecancer.2014.421
Gori E, Callea E, Alberani F, Orlando L. Microbial monitoring and methods of sample collection: a GITMO survey (Gruppo Trapianto di Midollo Osseo). Ecancermedicalscience. 2014 Apr 10;8:421. doi: 10.3332/ecancer.2014.421. eCollection 2014. PMID: 24834116; PMCID: PMC3998655.
Copy Download .nbib Format: NLM
Trends in the distribution of breast cancer over time in the southeast of Scotland and review of the literature.

Ecancermedicalscience

Aljarrah A, Miller WR.
PMID: 24834122
Ecancermedicalscience. 2014 May 06;8:427. doi: 10.3332/ecancer.2014.427. eCollection 2014.

INTRODUCTION: Breast cancer is the most common form of malignancy in Scottish women, and its incidence appears to be increasing with time. It is therefore important to identify factors associated with risk and outcome. Whilst breast cancer occurs equally...

Cite
Aljarrah A, Miller WR. Trends in the distribution of breast cancer over time in the southeast of Scotland and review of the literature. Ecancermedicalscience. 2014;8:427doi: 10.3332/ecancer.2014.427.
Aljarrah, A., & Miller, W. R. (2014). Trends in the distribution of breast cancer over time in the southeast of Scotland and review of the literature. Ecancermedicalscience, 8427. https://doi.org/10.3332/ecancer.2014.427
Aljarrah, A, and Miller, W R. "Trends in the distribution of breast cancer over time in the southeast of Scotland and review of the literature." Ecancermedicalscience vol. 8 (2014): 427. doi: https://doi.org/10.3332/ecancer.2014.427
Aljarrah A, Miller WR. Trends in the distribution of breast cancer over time in the southeast of Scotland and review of the literature. Ecancermedicalscience. 2014 May 06;8:427. doi: 10.3332/ecancer.2014.427. eCollection 2014. PMID: 24834122; PMCID: PMC4019459.
Copy Download .nbib Format: NLM
The cervical cancer prevention programme in Costa Rica.

Ecancermedicalscience

Rojas IQ.
PMID: 26557876
Ecancermedicalscience. 2015 Oct 08;9:578. doi: 10.3332/ecancer.2015.578. eCollection 2015.

Cervical and uterine cancer continues to be an important issue for women around the world, although neoplasia has the greatest demonstrated potential for prevention. Costa Rica has achieved important advances in the reduction of the incidence and mortality of...

Cite
Rojas IQ. The cervical cancer prevention programme in Costa Rica. Ecancermedicalscience. 2015;9:578doi: 10.3332/ecancer.2015.578.
Rojas, I. Q. (2015). The cervical cancer prevention programme in Costa Rica. Ecancermedicalscience, 9578. https://doi.org/10.3332/ecancer.2015.578
Rojas, Ileana Quirós. "The cervical cancer prevention programme in Costa Rica." Ecancermedicalscience vol. 9 (2015): 578. doi: https://doi.org/10.3332/ecancer.2015.578
Rojas IQ. The cervical cancer prevention programme in Costa Rica. Ecancermedicalscience. 2015 Oct 08;9:578. doi: 10.3332/ecancer.2015.578. eCollection 2015. PMID: 26557876; PMCID: PMC4631572.
Copy Download .nbib Format: NLM
Anti-androgenic effects of flavonols in prostate cancer.

Ecancermedicalscience

Boam T.
PMID: 26557883
Ecancermedicalscience. 2015 Oct 22;9:585. doi: 10.3332/ecancer.2015.585. eCollection 2015.

Dietary-derived agents, such as the flavonoids, are of particular interest for prostate cancer (PCa) chemoprevention as they may offer a favourable safety and side-effect profile. An agent that demonstrates action on the androgen receptor (AR) axis may have value...

Cite
Boam T. Anti-androgenic effects of flavonols in prostate cancer. Ecancermedicalscience. 2015;9:585doi: 10.3332/ecancer.2015.585.
Boam, T. (2015). Anti-androgenic effects of flavonols in prostate cancer. Ecancermedicalscience, 9585. https://doi.org/10.3332/ecancer.2015.585
Boam, Tristan. "Anti-androgenic effects of flavonols in prostate cancer." Ecancermedicalscience vol. 9 (2015): 585. doi: https://doi.org/10.3332/ecancer.2015.585
Boam T. Anti-androgenic effects of flavonols in prostate cancer. Ecancermedicalscience. 2015 Oct 22;9:585. doi: 10.3332/ecancer.2015.585. eCollection 2015. PMID: 26557883; PMCID: PMC4631581.
Copy Download .nbib Format: NLM
Cancer, obesity, and legitimation of suggested lifestyles: a libertarian paternalism approach.

Ecancermedicalscience

Boniolo G, Rebba V.
PMID: 26557886
Ecancermedicalscience. 2015 Oct 29;9:588. doi: 10.3332/ecancer.2015.588. eCollection 2015.

We know that around 30% of all cancers are preventable. We also know that there is clear evidence of the causal relations between obesity and cancer. This means that there could be lifestyles that could prevent obesity and, thus,...

Cite
Boniolo G, Rebba V. Cancer, obesity, and legitimation of suggested lifestyles: a libertarian paternalism approach. Ecancermedicalscience. 2015;9:588doi: 10.3332/ecancer.2015.588.
Boniolo, G., & Rebba, V. (2015). Cancer, obesity, and legitimation of suggested lifestyles: a libertarian paternalism approach. Ecancermedicalscience, 9588. https://doi.org/10.3332/ecancer.2015.588
Boniolo, Giovanni, and Rebba, Vincenzo. "Cancer, obesity, and legitimation of suggested lifestyles: a libertarian paternalism approach." Ecancermedicalscience vol. 9 (2015): 588. doi: https://doi.org/10.3332/ecancer.2015.588
Boniolo G, Rebba V. Cancer, obesity, and legitimation of suggested lifestyles: a libertarian paternalism approach. Ecancermedicalscience. 2015 Oct 29;9:588. doi: 10.3332/ecancer.2015.588. eCollection 2015. PMID: 26557886; PMCID: PMC4631582.
Copy Download .nbib Format: NLM
Expression of COX-2 and bcl-2 in oral lichen planus lesions and lichenoid reactions.

Ecancermedicalscience

Arreaza AJ, Rivera H, Correnti M.
PMID: 24834112
Ecancermedicalscience. 2014 Mar 20;8:411. doi: 10.3332/ecancer.2014.411. eCollection 2014.

UNLABELLED: Oral lichen planus and lichenoid reactions are autoimmune type inflammatory conditions of the oral mucosa with similar clinical and histological characteristics. Recent data suggest that oral lichenoid reactions (OLR) present a greater percentage of malignant transformation than oral...

Cite
Arreaza AJ, Rivera H, Correnti M. Expression of COX-2 and bcl-2 in oral lichen planus lesions and lichenoid reactions. Ecancermedicalscience. 2014;8:411doi: 10.3332/ecancer.2014.411.
Arreaza, A. J., Rivera, H., & Correnti, M. (2014). Expression of COX-2 and bcl-2 in oral lichen planus lesions and lichenoid reactions. Ecancermedicalscience, 8411. https://doi.org/10.3332/ecancer.2014.411
Arreaza, Alven J, et al. "Expression of COX-2 and bcl-2 in oral lichen planus lesions and lichenoid reactions." Ecancermedicalscience vol. 8 (2014): 411. doi: https://doi.org/10.3332/ecancer.2014.411
Arreaza AJ, Rivera H, Correnti M. Expression of COX-2 and bcl-2 in oral lichen planus lesions and lichenoid reactions. Ecancermedicalscience. 2014 Mar 20;8:411. doi: 10.3332/ecancer.2014.411. eCollection 2014. PMID: 24834112; PMCID: PMC3971871.
Copy Download .nbib Format: NLM
Regression of metastatic colon tumour from primary adenocarcinoma of the lung due to fistulisation to the bowel lumen.

Ecancermedicalscience

Iwamuro M, Miyabe Y, Hanae K, Yoshinari K, Katsuyoshi T, Murakami T, Hirofumi M, Yamamoto K.
PMID: 24834113
Ecancermedicalscience. 2014 Mar 20;8:412. doi: 10.3332/ecancer.2014.412. eCollection 2014.

An 80-year-old Japanese male was diagnosed with pulmonary adenocarcinoma. The patient exhibited extensive extra pulmonary involvement in the bone, adrenal gland, abdominal lymph nodes, and sigmoid colon. A single course of chemotherapy with carboplatin and pemetrexed was administered as...

Cite
Iwamuro M, Miyabe Y, Hanae K, et al. Regression of metastatic colon tumour from primary adenocarcinoma of the lung due to fistulisation to the bowel lumen. Ecancermedicalscience. 2014;8:412doi: 10.3332/ecancer.2014.412.
Iwamuro, M., Miyabe, Y., Hanae, K., Yoshinari, K., Katsuyoshi, T., Murakami, T., Hirofumi, M., & Yamamoto, K. (2014). Regression of metastatic colon tumour from primary adenocarcinoma of the lung due to fistulisation to the bowel lumen. Ecancermedicalscience, 8412. https://doi.org/10.3332/ecancer.2014.412
Iwamuro, Masaya, et al. "Regression of metastatic colon tumour from primary adenocarcinoma of the lung due to fistulisation to the bowel lumen." Ecancermedicalscience vol. 8 (2014): 412. doi: https://doi.org/10.3332/ecancer.2014.412
Iwamuro M, Miyabe Y, Hanae K, Yoshinari K, Katsuyoshi T, Murakami T, Hirofumi M, Yamamoto K. Regression of metastatic colon tumour from primary adenocarcinoma of the lung due to fistulisation to the bowel lumen. Ecancermedicalscience. 2014 Mar 20;8:412. doi: 10.3332/ecancer.2014.412. eCollection 2014. PMID: 24834113; PMCID: PMC3971873.
Copy Download .nbib Format: NLM
Oncology pharmacy units: a safety policy for handling hazardous drugs and related waste in low- and middle-income African countries-Angolan experience.

Ecancermedicalscience

da Conceição AV, Bernardo D, Lopes LV, Miguel F, Bessa F, Monteiro F, Santos C, Oliveira B, Santos LL.
PMID: 26557873
Ecancermedicalscience. 2015 Oct 01;9:575. doi: 10.3332/ecancer.2015.575. eCollection 2015.

In African countries, higher rates of late-stage cancers at the time of first diagnosis are a reality. In this context, hazardous drugs (HDs), such as chemotherapy, play an important role and have immense benefits for patients' treatment. HDs should...

Cite
da Conceição AV, Bernardo D, Lopes LV, et al. Oncology pharmacy units: a safety policy for handling hazardous drugs and related waste in low- and middle-income African countries-Angolan experience. Ecancermedicalscience. 2015;9:575doi: 10.3332/ecancer.2015.575.
da Conceição, A. V., Bernardo, D., Lopes, L. V., Miguel, F., Bessa, F., Monteiro, F., Santos, C., Oliveira, B., & Santos, L. L. (2015). Oncology pharmacy units: a safety policy for handling hazardous drugs and related waste in low- and middle-income African countries-Angolan experience. Ecancermedicalscience, 9575. https://doi.org/10.3332/ecancer.2015.575
da Conceição, Ana Vaz, et al. "Oncology pharmacy units: a safety policy for handling hazardous drugs and related waste in low- and middle-income African countries-Angolan experience." Ecancermedicalscience vol. 9 (2015): 575. doi: https://doi.org/10.3332/ecancer.2015.575
da Conceição AV, Bernardo D, Lopes LV, Miguel F, Bessa F, Monteiro F, Santos C, Oliveira B, Santos LL. Oncology pharmacy units: a safety policy for handling hazardous drugs and related waste in low- and middle-income African countries-Angolan experience. Ecancermedicalscience. 2015 Oct 01;9:575. doi: 10.3332/ecancer.2015.575. eCollection 2015. PMID: 26557873; PMCID: PMC4631569.
Copy Download .nbib Format: NLM
How do medical journalists treat cancer-related issues?.

Ecancermedicalscience

Nakada H, Tsubokura M, Kishi Y, Yuji K, Matsumura T, Kami M.
PMID: 25729415
Ecancermedicalscience. 2015 Jan 26;9:502. doi: 10.3332/ecancer.2015.502. eCollection 2015.

Cancer patients can obtain information about their illness through a variety of media sources. Therefore, it is important to know how medical journalists treat cancer-related issues; to that end, we sent self-administered questionnaires to 364 journalists in 82 organisations...

Cite
Nakada H, Tsubokura M, Kishi Y, et al. How do medical journalists treat cancer-related issues?. Ecancermedicalscience. 2015;9:502doi: 10.3332/ecancer.2015.502.
Nakada, H., Tsubokura, M., Kishi, Y., Yuji, K., Matsumura, T., & Kami, M. (2015). How do medical journalists treat cancer-related issues?. Ecancermedicalscience, 9502. https://doi.org/10.3332/ecancer.2015.502
Nakada, Haruka, et al. "How do medical journalists treat cancer-related issues?." Ecancermedicalscience vol. 9 (2015): 502. doi: https://doi.org/10.3332/ecancer.2015.502
Nakada H, Tsubokura M, Kishi Y, Yuji K, Matsumura T, Kami M. How do medical journalists treat cancer-related issues?. Ecancermedicalscience. 2015 Jan 26;9:502. doi: 10.3332/ecancer.2015.502. eCollection 2015. PMID: 25729415; PMCID: PMC4335961.
Copy Download .nbib Format: NLM
Report from the 37th san antonio breast cancer symposium, 9-13th december 2014, Texas, USA.

Ecancermedicalscience

Ahmed M, Esposito E.
PMID: 25729421
Ecancermedicalscience. 2015 Feb 04;9:508. doi: 10.3332/ecancer.2015.508. eCollection 2015.

The 37th San Antonio Breast Cancer Symposium (SABCS) was held at the Henry B. Gonzalez Conference Centre in San Antonio, Texas, USA between the 9 and 13th of December 2014. It brought together an interaction between basic scientists and...

Cite
Ahmed M, Esposito E. Report from the 37th san antonio breast cancer symposium, 9-13th december 2014, Texas, USA. Ecancermedicalscience. 2015;9:508doi: 10.3332/ecancer.2015.508.
Ahmed, M., & Esposito, E. (2015). Report from the 37th san antonio breast cancer symposium, 9-13th december 2014, Texas, USA. Ecancermedicalscience, 9508. https://doi.org/10.3332/ecancer.2015.508
Ahmed, M, and Esposito, E. "Report from the 37th san antonio breast cancer symposium, 9-13th december 2014, Texas, USA." Ecancermedicalscience vol. 9 (2015): 508. doi: https://doi.org/10.3332/ecancer.2015.508
Ahmed M, Esposito E. Report from the 37th san antonio breast cancer symposium, 9-13th december 2014, Texas, USA. Ecancermedicalscience. 2015 Feb 04;9:508. doi: 10.3332/ecancer.2015.508. eCollection 2015. PMID: 25729421; PMCID: PMC4335966.
Copy Download .nbib Format: NLM
Report on the 56th ASH Annual Meeting, San Francisco, 4-9 December 2014.

Ecancermedicalscience

Agazzi A.
PMID: 25729427
Ecancermedicalscience. 2015 Feb 26;9:514. doi: 10.3332/ecancer.2015.514. eCollection 2015.

The 56th annual ASH (American Society of Haematology) meeting was held in San Francisco (CA). More than 3,000 abstracts were selected for presentation due to the huge amount of information from basic science to clinical experience. The future direction...

Cite
Agazzi A. Report on the 56th ASH Annual Meeting, San Francisco, 4-9 December 2014. Ecancermedicalscience. 2015;9:514doi: 10.3332/ecancer.2015.514.
Agazzi, A. (2015). Report on the 56th ASH Annual Meeting, San Francisco, 4-9 December 2014. Ecancermedicalscience, 9514. https://doi.org/10.3332/ecancer.2015.514
Agazzi, Alberto. "Report on the 56th ASH Annual Meeting, San Francisco, 4-9 December 2014." Ecancermedicalscience vol. 9 (2015): 514. doi: https://doi.org/10.3332/ecancer.2015.514
Agazzi A. Report on the 56th ASH Annual Meeting, San Francisco, 4-9 December 2014. Ecancermedicalscience. 2015 Feb 26;9:514. doi: 10.3332/ecancer.2015.514. eCollection 2015. PMID: 25729427; PMCID: PMC4341995.
Copy Download .nbib Format: NLM
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.

Ecancermedicalscience

Van Nuffel AM, Sukhatme V, Pantziarka P, Meheus L, Sukhatme VP, Bouche G.
PMID: 25729426
Ecancermedicalscience. 2015 Feb 24;9:513. doi: 10.3332/ecancer.2015.513. eCollection 2015.

Clarithromycin (CAM) is a well-known macrolide antibiotic available as a generic drug. CAM is traditionally used for many types of bacterial infections, treatment of Lyme disease and eradication of gastric infection with Helicobacter pylori. Extensive preclinical and clinical data...

Cite
Van Nuffel AM, Sukhatme V, Pantziarka P, et al. Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent. Ecancermedicalscience. 2015;9:513doi: 10.3332/ecancer.2015.513.
Van Nuffel, A. M., Sukhatme, V., Pantziarka, P., Meheus, L., Sukhatme, V. P., & Bouche, G. (2015). Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent. Ecancermedicalscience, 9513. https://doi.org/10.3332/ecancer.2015.513
Van Nuffel, An Mt, et al. "Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent." Ecancermedicalscience vol. 9 (2015): 513. doi: https://doi.org/10.3332/ecancer.2015.513
Van Nuffel AM, Sukhatme V, Pantziarka P, Meheus L, Sukhatme VP, Bouche G. Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent. Ecancermedicalscience. 2015 Feb 24;9:513. doi: 10.3332/ecancer.2015.513. eCollection 2015. PMID: 25729426; PMCID: PMC4341996.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1300 entries